Abstract 235P
Background
Radiation therapy (RT) is not a standard treatment for ovarian cancer (OC). However, it can be used as an adjunctive therapy to control the local recurrent disease. We aimed to investigate whether OC patients could benefit from RT.
Methods
From 2004 to 2013, the incidence, survival, treatment, and end results data from the SEER were analyzed for cases diagnosed with OC. We examined cause-specific survival (CSS) and overall survival (OS) with 95% confidence intervals (CIs) to estimate the effect of RT from multivariate Cox regression analysis. Performed propensity score matching (PSM) method was used for OC patients who received radiotherapy versus those who did not.
Results
A total of 11140 cases were enrolled for analysis. The aggregated HR of univariate survival analysis suggested that radiotherapy had unfavorable effects on overall survival (HR 1.315, 95% CI 0.994–1.739, P = 0.055) and cancer-specific survival (HR 1.732, 95% CI 1.285–2.334, P < 0.001), but there is no significant difference in multivariate analysis (OS HR 1.315, 95% CI 0.994–1.739, P = 0.055; CSS HR 1.222, 95% CI 0.905–1.651, P = 0.191). After PSM by 1:4, 655 patients were included. Both of the effect of radiotherapy in overall survival (HR 1.341, 95% CI 0.977–1.84, P = 0.070) and cancer-specific survival (HR 1.309, 95% CI 0.931–1.838, P = 0.121) were not significant ever in univariate analysis. Multivariate analysis also found the same results (OS HR 1.232, 95% CI 0.894–1.699, P = 0.202; CSS HR 1.187, 95% CI 0.841–1.674, P = 0.330). Radiotherapy seems to have a reverse effect in regionally spread patients in stage II patients (before PMS HR 3.154, 95% CI 1.709-5.821, p < 0.01; after PMS HR = 3.543, 95% CI 1.603-7.834, p < 0.01) and non-epithelial OC patients (before PMS HR 1.748, 95% CI 1.219-2.507, p = 0.002; after PMS HR = 1.5422, 95% CI 1.021-2.329, p = 0.04).
Conclusions
In OC patients, RT does not have a proven benefit on CSS and OS overall, and it is especially not suitable for early-stage patients and non-epithelial OC patients. However, further confirmation is needed from well-designed and large-scale RCTs in the future to identify its effect in certain types of epithelial OC patients after the developed techniques.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
YO10 - Rectal Follicular Dendritic Cell Sarcoma
Presenter: Kripa Bajaj
Session: Poster display session
Resources:
Abstract
YO11 - Postoperative metastasis prediction based on portal vein circulating tumor cells detected by flow cytometry in periampullary or pancreatic cancer
Presenter: Lianyuan Tao
Session: Poster display session
Resources:
Abstract
YO12 - Case report of Hepatic EBV-associated smooth muscle tumor in AIDS patient
Presenter: Gorawich Kerkarchachai
Session: Poster display session
Resources:
Abstract
YO13 - IgG4-related pseudo-tumor of the kidney and multiple organ involvement mimicked malignancy
Presenter: Wasamol Mahaparn
Session: Poster display session
Resources:
Abstract
YO14 - Urachal Adenocarcinoma: Case Report
Presenter: Michelle Joane Alcantara
Session: Poster display session
Resources:
Abstract
YO15 - Concurrent Atezolizumab-Radiotherapy in Locally Recurrent Urinary Bladder Carcinoma: A Case Report
Presenter: Ma. Angelle Lalaine Dantes
Session: Poster display session
Resources:
Abstract
YO16 - Clear cell RCC with synchronous metastasis at transplanted kidney and bone in patient post Cadaveric donor kidney transplantation
Presenter: Punyaporn Cheewasathianchai
Session: Poster display session
Resources:
Abstract
YO17 - Serous ovarian cancer treated with palbociclib and letrozole
Presenter: Dai Wee Lee
Session: Poster display session
Resources:
Abstract
YO18 - A patient with Peutz-Jegher syndrome who incidentally found sex cord stromal tumor: a case report
Presenter: Pongput Pimsa
Session: Poster display session
Resources:
Abstract
YO19 - A case of CLL/SLL with transdifferentiation to dendritic cell tumor and possibly a hybrid lymphodendritic cell neoplasm:The missing link?
Presenter: Yanping Chen
Session: Poster display session
Resources:
Abstract